연구성과로 돌아가기
2024 연구성과별 연구자 정보 (61 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Park, J. S. | Park, JS | 20 | Daegu Catholic Univ, Med Ctr, Dept Urol, Daegu, South Korea | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Kwon, T. G. | Kwon, TG | 21 | Kyungpook Natl Univ, Chilgok Hosp, Dept Urol, Daegu, South Korea | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Chung, J. I. | Chung, JI | 22 | Inje Univ, Busan Paik Hosp, Dept Urol, Busan, South Korea | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Park, S. W. | Park, SW | 23 | Pusan Natl Univ, Yansan Hosp, Dept Urol, Yangsan, South Korea | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Lee, K. S. | Lee, KS | 24 | Keimyung Univ, Dongsan Hosp, Dept Urol, Daegu, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Sohn, Joohyuk | Sohn, J | 1 | Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Kim, Gun Min | Kim, GM | 2 | Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Jung, Kyung Hae | Jung, KH | 3 | Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Jeung, Hei-Cheul | Jeung, HC | 4 | Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Med Oncol,Dept Internal Med, Seoul, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Lee, Jieun | Lee, J | 5 | Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Med Oncol, Seoul, South Korea | JXX-7773-2024 | Lee, Jieun | ||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Lee, Keun Seok | Lee, KS | 6 | Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Im, Seock-Ah | Im, SA | 7 | Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea | J-5620-2012 | Im, Seock-Ah | ||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Kang, Seok Yun | Kang, SY | 8 | Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea | ACI-8824-2022 | KANG, MIN KYU | ||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Kim, Se Hyun | Kim, SH | 9 | Seoul Natl Univ, Dept Internal Med, Seoul, South Korea | ||||||
| A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial. | Kim, Han Jo | Kim, HJ | 10 | Soonchunhyang Univ Hosp, Cheonan, Chungcheongnam, South Korea |
페이지 이동: